37 related articles for article (PubMed ID: 25620080)
1. Evaluation of HLA-G 14bp Ins/Del and +3142 C/G Polymorphisms in Type 1 Diabetes among South Indian Population.
Gunavathy N; Asirvatham A; Chitra A; Jayalakshmi M
Indian J Endocrinol Metab; 2023; 27(3):223-229. PubMed ID: 37583409
[TBL] [Abstract][Full Text] [Related]
2. Association Between Polymorphism in Diabetes Susceptibility Gene Insulin-Like Growth Factor 2mRNA-Binding Protein 2 and Risk of Diffuse Large B-Cell Lymphoma.
Zhou W; Gao Q; He C; Wang L; Wang Y; Feng L; Li W; Liu W; Ma R; Liu L
Clin Med Insights Oncol; 2023; 17():11795549231201128. PubMed ID: 37823009
[TBL] [Abstract][Full Text] [Related]
3. HLA-G and MHC Class II Protein Expression in Diffuse Large B-Cell Lymphoma.
Jesionek-Kupnicka D; Bojo M; Prochorec-Sobieszek M; Szumera-Ciećkiewicz A; Jabłońska J; Kalinka-Warzocha E; Kordek R; Młynarski W; Robak T; Warzocha K; Lech-Maranda E
Arch Immunol Ther Exp (Warsz); 2016 Jun; 64(3):225-40. PubMed ID: 26667793
[TBL] [Abstract][Full Text] [Related]
4. Loss of HLA-DR expression is related to tumor microenvironment and predicts adverse outcome in diffuse large B-cell lymphoma.
Higashi M; Tokuhira M; Fujino S; Yamashita T; Abe K; Arai E; Kizaki M; Tamaru J
Leuk Lymphoma; 2016; 57(1):161-6. PubMed ID: 25860238
[TBL] [Abstract][Full Text] [Related]
5. Individual HLA heterogeneity and its implications for cellular immune evasion in cancer and beyond.
Pagliuca S; Gurnari C; Rubio MT; Visconte V; Lenz TL
Front Immunol; 2022; 13():944872. PubMed ID: 36131910
[TBL] [Abstract][Full Text] [Related]
6. HLA-G and single nucleotide polymorphism (SNP) associations with cancer in African populations: Implications in personal medicine.
Adolf IC; Almars A; Dharsee N; Mselle T; Akan G; Nguma IJ; Nateri AS; Atalar F
Genes Dis; 2022 Sep; 9(5):1220-1233. PubMed ID: 35873024
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation in the
Jiang Y; Lu J; Wu YE; Zhao X; Li L
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30962267
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of Immune Evasion and Immune Modulation by Lymphoma Cells.
Menter T; Tzankov A
Front Oncol; 2018; 8():54. PubMed ID: 29564225
[TBL] [Abstract][Full Text] [Related]
9. HLA-G 3'UTR Polymorphisms Predict Drug-Induced G3-4 Toxicity Related to Folinic Acid/5-Fluorouracil/Oxaliplatin (FOLFOX4) Chemotherapy in Non-Metastatic Colorectal Cancer.
Garziera M; Virdone S; De Mattia E; Scarabel L; Cecchin E; Polesel J; D'Andrea M; Pella N; Buonadonna A; Favaretto A; Toffoli G
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28653974
[TBL] [Abstract][Full Text] [Related]
10. Diffuse large B-cell lymphoma: R-CHOP failure-what to do?
Coiffier B; Sarkozy C
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):366-378. PubMed ID: 27913503
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances in Our Understanding of HLA-G Biology: Lessons from a Wide Spectrum of Human Diseases.
Morandi F; Rizzo R; Fainardi E; Rouas-Freiss N; Pistoia V
J Immunol Res; 2016; 2016():4326495. PubMed ID: 27652273
[TBL] [Abstract][Full Text] [Related]
12. HLA-G expression and role in advanced-stage classical Hodgkin lymphoma.
Caocci G; Greco M; Fanni D; Senes G; Littera R; Lai S; Risso P; Carcassi C; Faa G; La Nasa G
Eur J Histochem; 2016 Apr; 60(2):2606. PubMed ID: 27349312
[TBL] [Abstract][Full Text] [Related]
13. Human Leukocyte Antigen-G (HLA-G) Expression in Cancers: Roles in Immune Evasion, Metastasis and Target for Therapy.
Lin A; Yan WH
Mol Med; 2015 Nov; 21(1):782-791. PubMed ID: 26322846
[TBL] [Abstract][Full Text] [Related]
14. Human leukocyte antigen-G polymorphisms influence the clinical outcome in diffuse large B-cell lymphoma.
Bielska M; Bojo M; Klimkiewicz-Wojciechowska G; Jesionek-Kupnicka D; Borowiec M; Kalinka-Warzocha E; Prochorec-Sobieszek M; Robak T; Warzocha K; Młynarski W; Lech-Maranda E
Genes Chromosomes Cancer; 2015 Mar; 54(3):185-93. PubMed ID: 25620080
[TBL] [Abstract][Full Text] [Related]
15. Association of an HLA-G 14-bp Insertion/Deletion polymorphism with high HBV replication in chronic hepatitis.
Laaribi AB; Zidi I; Hannachi N; Ben Yahia H; Chaouch H; Bortolotti D; Zidi N; Letaief A; Yacoub S; Boudabous A; Rizzo R; Boukadida J
J Viral Hepat; 2015 Oct; 22(10):835-41. PubMed ID: 25619305
[TBL] [Abstract][Full Text] [Related]
16. Association between sHLA-G and HLA-G 14-bp deletion/insertion polymorphism in Crohn's disease.
Zidi I; Ben Yahia H; Bortolotti D; Mouelhi L; Laaribi AB; Ayadi S; Zidi N; Houissa F; Debbech R; Boudabous A; Najjar T; Di Luca D; Rizzo R
Int Immunol; 2015 Jun; 27(6):289-96. PubMed ID: 25577194
[TBL] [Abstract][Full Text] [Related]
17. HLA-G Gene Polymorphism in Egyptian Patients with Non-Hodgkin Lymphoma and its Clinical Outcome.
Tawfeek GA; Alhassanin S
Immunol Invest; 2018 Apr; 47(3):315-325. PubMed ID: 29388862
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of the relationship between 14bp insertion/deletion polymorphism of HLA-G gene and susceptibility to systemic lupus erythematosus.
Zhang X; Li S; Zhang Y; Lu Y; Wang J; Xu J; Li X; Qin X
Hum Immunol; 2014 Dec; 75(12):1171-6. PubMed ID: 25454623
[TBL] [Abstract][Full Text] [Related]
19. Association between human leukocyte antigen-G 14-bp insertion/deletion polymorphism and cancer risk: a meta-analysis and systematic review.
Ge YZ; Ge Q; Li MH; Shi GM; Xu X; Xu LW; Xu Z; Lu TZ; Wu R; Zhou LH; Wu JP; Liang K; Dou QL; Zhu JG; Li WC; Jia RP
Hum Immunol; 2014 Aug; 75(8):827-32. PubMed ID: 24952208
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
